Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
21 "Jin Lee"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Letters to the Editor
IBD
Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know
Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Seung-Jae Myung, Clinical Practice Guideline Committee of the Korean Association for the Study of Intestinal Diseases
Intest Res 2022;20(3):386-388.   Published online March 11, 2022
DOI: https://doi.org/10.5217/ir.2020.00172
PDFPubReaderePub
  • 4,385 View
  • 329 Download
Close layer
Statements
IBD
Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements
Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung
Intest Res 2022;20(4):431-444.   Published online January 5, 2022
DOI: https://doi.org/10.5217/ir.2021.00111
AbstractAbstract PDFPubReaderePub
Many unexpected problems have resulted from the unprecedented coronavirus disease 2019 (COVID-19) pandemic. The optimal management of patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic has also been a challenge. Therefore, the Korean Association for the Study of Intestinal Diseases (KASID) developed a consensus statement of experts regarding the management of IBD during the COVID-19 pandemic. This consensus statement made recommendations regarding the risk and treatment of COVID-19 in IBD patients. This statement emphasizes that IBD is not a risk factor for COVID-19, and care should be taken not to exacerbate IBD in patients in remission state by maintaining their medications, except for corticosteroids.

Citations

Citations to this article as recorded by  
  • Mobile monitoring system detects the disease activity pattern and shows the association with clinical outcomes in patients with newly diagnosed Crohn’s disease
    Yoo Jin Lee, Sang Gyu Kwak, Eun Soo Kim, Sung Kook Kim, Hyun Seok Lee, Yun Jin Chung, Byung Ik Jang, Kyeong Ok Kim, Jeongseok Kim, Hyeong Ho Jo, Eun Young Kim
    Scientific Reports.2024;[Epub]     CrossRef
  • Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know
    Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Seung-Jae Myung
    Intestinal Research.2022; 20(3): 386.     CrossRef
  • 5,973 View
  • 550 Download
  • 2 Web of Science
  • 2 Crossref
Close layer
IBD
SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID
Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seung-Jae Myung, The Clinical Practice Guideline Committee of the Korean Association for the Study of the Intestinal Diseases (KASID)
Intest Res 2022;20(2):171-183.   Published online January 5, 2022
DOI: https://doi.org/10.5217/ir.2021.00098
AbstractAbstract PDFPubReaderePub
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus, is threatening global health worldwide with unprecedented contagiousness and severity. The best strategy to overcome COVID-19 is a vaccine. Various vaccines are currently being developed, and mass vaccination is in progress. Despite the very encouraging clinical trial results of these vaccines, there is insufficient information on the safety and efficacy of vaccines for inflammatory bowel disease (IBD) patients facing various issues. After reviewing current evidence and international guidelines, the Korean Association for the Study of Intestinal Diseases developed an expert consensus statement on COVID-19 vaccination issues for Korean IBD patients. This expert consensus statement emphasizes that severe acute respiratory syndrome coronavirus 2 vaccination be strongly recommended for IBD patients, and it is safe for IBD patients receiving immunomodulatory therapy.

Citations

Citations to this article as recorded by  
  • COVID-19 vaccine updates for people under different conditions
    Yijiao Huang, Weiyang Wang, Yan Liu, Zai Wang, Bin Cao
    Science China Life Sciences.2024; 67(11): 2323.     CrossRef
  • Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea
    Jung Hyun Ji, Seung Hwan Shin, Yong Eun Park, Jihye Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim, Sang-Bum Kang, Sang Hyoung Park, Soo Jung Park
    Intestinal Research.2024; 22(3): 336.     CrossRef
  • Vaccination in patients with inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
    Su Bum Park, Kyeong Ok Kim, Hong Sub Lee, Chang Hwan Choi, Shu Chen Wei, Min Hu Chen, Katsuyoshi Matsuoka
    Intestinal Research.2023; 21(3): 363.     CrossRef
  • Beyond the survey, to the ideal therapy for Asian
    Ki Jae Jo, Jong Pil Im
    Intestinal Research.2023; 21(3): 280.     CrossRef
  • Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know
    Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Seung-Jae Myung
    Intestinal Research.2022; 20(3): 386.     CrossRef
  • Vaccination strategies for Korean patients with inflammatory bowel disease
    Yoo Jin Lee, Eun Soo Kim
    The Korean Journal of Internal Medicine.2022; 37(5): 920.     CrossRef
  • SARS-CoV-2 Infection and Outcomes in Children with Inflammatory Bowel Diseases: A Systematic Review
    Anastasia Batsiou, Petros Mantzios, Daniele Piovani, Andreas G. Tsantes, Paschalia Kopanou Taliaka, Paraskevi Liakou, Nicoletta Iacovidou, Argirios E. Tsantes, Stefanos Bonovas, Rozeta Sokou
    Journal of Clinical Medicine.2022; 11(23): 7238.     CrossRef
  • 6,039 View
  • 352 Download
  • 7 Web of Science
  • 7 Crossref
Close layer
Original Articles
IBD
Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease
Seong Jae Yeo, Hyun Seok Lee, Byung Ik Jang, Eun Soo Kim, Seong Woo Jeon, Sung Kook Kim, Kyeong Ok Kim, Yoo Jin Lee, Hyun Jik Lee, Kyung Sik Park, Yun Jin Jung, Eun Young Kim, Chang Heon Yang
Intest Res 2018;16(3):400-408.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.400
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

This study aimed to elucidate the prevalence of hepatitis B virus (HBV) serologic markers in Korean patients newly diagnosed with, but not yet treated for inflammatory bowel disease (IBD).

Methods

We prospectively enrolled 210 patients newly diagnosed with IBD (109 with ulcerative colitis and 101 with Crohn's disease). Hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), and hepatitis B core antibody (anti-HBc) levels were measured and compared with those of 1,100 sex- and age-matched controls.

Results

The prevalence of chronic HBV infection (positive HBsAg, positive anti-HBc, and negative anti-HBs results) and past infection (negative HBsAg, positive anti-HBc, and positive or negative anti-HBs results) were not significantly different between the patients and controls (chronic HBV infection: IBD, 3.8% vs. control, 4.9%, P=0.596; past infection: IBD, 26.2% vs. control, 28.8%, P=0.625). The patients with IBD aged <20 years were at a higher susceptibility risk (nonimmune) for HBV infection than the controls (IBD, 41.5% vs. control, 22.4%; P=0.018). In the multivariate analysis, an age of <20 years (P=0.024) and symptom duration of ≥12 months before diagnosis (P=0.027) were identified as independent risk factors for nonimmunity against HBV infection.

Conclusions

The patients newly diagnosed with IBD were susceptible to HBV infection. The frequency of nonimmunity was high, especially in the patients aged <20 years and those with a longer duration of symptoms before diagnosis. Therefore, it is necessary to screen for HBV serologic markers and generate a detailed vaccination plan for patients newly diagnosed with IBD.

Citations

Citations to this article as recorded by  
  • Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Sunil Kasturi, Amrit Gopan, Sridhar Sundaram, Aditya Kale
    Intestinal Research.2023; 21(3): 392.     CrossRef
  • Viral Hepatitis in Patients with Inflammatory Bowel Disease
    Seung Hwan Shin, Sang Hyoung Park
    The Korean Journal of Gastroenterology.2022; 80(2): 51.     CrossRef
  • Vaccination strategies for Korean patients with inflammatory bowel disease
    Yoo Jin Lee, Eun Soo Kim
    The Korean Journal of Internal Medicine.2022; 37(5): 920.     CrossRef
  • Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment
    Georgios Axiaris, Evanthia Zampeli, Spyridon Michopoulos, Giorgos Bamias
    World Journal of Gastroenterology.2021; 27(25): 3762.     CrossRef
  • Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
    Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park, Yoon Tae Jeen
    Intestinal Research.2020; 18(1): 18.     CrossRef
  • Evaluating Hepatitis B Seroprotection and Revaccination for Children With Inflammatory Bowel Disease
    Erica J Brenner, Ravi Jhaveri, Michael D Kappelman, Ajay S Gulati
    Inflammatory Bowel Diseases.2019; 25(9): e108.     CrossRef
  • The importance of immunization in immune-mediated inflammatory disease cannot be overstated
    Sang Hyoung Park
    Intestinal Research.2018; 16(3): 325.     CrossRef
  • 7,689 View
  • 100 Download
  • 7 Web of Science
  • 7 Crossref
Close layer
IBD
Characteristics and management of patients with inflammatory bowel disease between a secondary and tertiary hospitals: a propensity score analysis
Ki Hwan Song, Eun Soo Kim, Yoo Jin Lee, Byung Ik Jang, Kyeong Ok Kim, Sang Gyu Kwak, Hyun Seok Lee
Intest Res 2018;16(2):216-222.   Published online April 30, 2018
DOI: https://doi.org/10.5217/ir.2018.16.2.216
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

This study aimed to compare the clinical characteristics and management patterns of inflammatory bowel disease (IBD) patients in a secondary hospital (SH) with those in tertiary referral centers (TRC).

Methods

Data from IBD patients in SH and 2 TRCs were retrospectively reviewed. The cumulative thiopurine use rate was compared between hospitals after controlling for different baseline characteristics using propensity score matching.

Results

Among the total of 447 patients with IBD, 178 Crohn's disease (CD) and 269 ulcerative colitis (UC) patients were included. Regarding initial CD symptoms, patients from SH were more likely to show perianal symptoms, such as anal pain or discharge (56.6% vs. 34.3%, P=0.003), whereas those from TRCs more often had luminal symptoms, such as abdominal pain (54.9% vs. 17.1%, P<0.001), diarrhea (44.1% vs. 18.4%, P<0.001), and body weight loss (9.8% vs. 1.3%, P=0.025). Complicating behaviors, such as stricturing and penetrating, were significantly higher in TRCs, while perianal disease was more common in SH. Ileal location was more frequently observed in TRCs. For UC, SH had a more limited extent of disease (proctitis 58.8% vs. 21.2%, P<0.001). The cumulative azathioprine use rate in SH was significantly lower than that in TRCs in both CD and UC patients after controlling for disease behavior, location, and perianal disease of CD and extent of UC.

Conclusions

The clinical characteristics and management of the IBD patients in SH were substantially different from those in TRCs. Thiopurine treatment was less commonly used for SH patients.

Citations

Citations to this article as recorded by  
  • Early course of newly diagnosed moderate‐to‐severe ulcerative colitis in Korea: Results from a hospital‐based inception cohort study (MOSAIK)
    Jin Young Yoon, Jae Myung Cha, Chang Kyun Lee, Young Sook Park, Kyu Chan Huh, Jeong Eun Shin, You Sun Kim, Chang Soo Eun, Soon Man Yoon, Jae Hee Cheon, Young Soo Park, Byong Duk Ye, YoungJa Lee, Youngdoe Kim, Hyo Jong Kim
    Journal of Gastroenterology and Hepatology.2021; 36(8): 2149.     CrossRef
  • VALIDation of the IBD-Disk Instrument for Assessing Disability in Inflammatory Bowel Diseases in a French Cohort: The VALIDate Study
    Catherine Le Berre, Mathurin Flamant, Guillaume Bouguen, Laurent Siproudhis, Marie Dewitte, Nina Dib, Elodie Cesbron-Metivier, Thomas Goronflot, Matthieu Hanf, Pierre-Antoine Gourraud, Elise Kerdreux, Alexandra Poinas, Arnaud Bourreille, Caroline Trang-Po
    Journal of Crohn's and Colitis.2020; 14(11): 1512.     CrossRef
  • 5,973 View
  • 57 Download
  • 2 Web of Science
  • 2 Crossref
Close layer
Case Report
IBD
A case of pemphigus vulgaris associated with ulcerative colitis
Joo Wan Seo, Jongha Park, Jin Lee, Mi Young Kim, Hyun Ju Choi, Heui Jeong Jeong, Ji Woon Lee, So Young Jung, Woo Kyeong Kim
Intest Res 2018;16(1):147-150.   Published online January 18, 2018
DOI: https://doi.org/10.5217/ir.2018.16.1.147
AbstractAbstract PDFPubReaderePub

Pemphigus vulgaris is an autoimmune bullous disorder characterized by the production of autoantibodies against the intercellular space of the epithelium. It has rarely been reported in association with inflammatory bowel disease. Ulcerative colitis is one of the forms of inflammatory bowel disease. A 62-year-old woman who had been treated for ulcerative colitis for 16 years developed pruritic bullae on the skin of her face and body. Histological findings and direct immunofluorescence examination of the skin showed pemphigus vulgaris. She was treated with systemic steroids, mesalazine, and azathioprine. Her cutaneous lesions have remained in remission and her ulcerative colitis has remained well-controlled. The relationship between pemphigus vulgaris and ulcerative colitis is unclear. An autoimmune response has been suspected in the pathogenesis of ulcerative colitis. Pemphigus vulgaris is also associated with an autoimmune mechanism. To our knowledge, this is the first case of ulcerative colitis associated with pemphigus vulgaris reported in Korea. The association may be causal.

Citations

Citations to this article as recorded by  
  • Autoimmune pemphigus: difficulties in diagnosis and the molecular mechanisms underlying the disease
    Olga Simionescu, Sorin Ioan Tudorache
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Persistent Scattered Pustules: Vesiculopustular IgA Pemphigus Arising in a Patient With Ulcerative Colitis
    Melissa M. Warne, Matthew F. Helm, Andrew Gaddi, Raminder Grover
    The American Journal of Dermatopathology.2023; 45(5): 350.     CrossRef
  • Cell-Matrix Interactions Contribute to Barrier Function in Human Colon Organoids
    James Varani, Shannon D. McClintock, Muhammad N. Aslam
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview
    Kyla Pagani, Danitza Lukac, Aashni Bhukhan, Jean S. McGee
    American Journal of Clinical Dermatology.2022; 23(4): 481.     CrossRef
  • Deep pemphigus (pemphigus vulgaris, pemphigus vegetans and paraneoplastic pemphigus) in dogs, cats and horses: a comprehensive review
    Heng L. Tham, Keith E. Linder, Thierry Olivry
    BMC Veterinary Research.2020;[Epub]     CrossRef
  • 7,875 View
  • 58 Download
  • 5 Web of Science
  • 5 Crossref
Close layer
Original Articles
Infection
Rapid and accurate diagnosis of Clostridium difficile infection by real-time polymerase chain reaction
Pil Hun Song, Jung Hwa Min, You Sun Kim, Soo Yeon Jo, Eun Jin Kim, Kyung Jin Lee, Jeonghun Lee, Hyun Sung, Jeong Seop Moon, Dong Hee Whang
Intest Res 2018;16(1):109-115.   Published online January 18, 2018
DOI: https://doi.org/10.5217/ir.2018.16.1.109
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

The incidence and severity of Clostridium difficile infection (CDI) have increased worldwide, resulting in a need for rapid and accurate diagnostic methods.

Methods

A retrospective study was conducted to compare CDI diagnosis methods between January 2014 and December 2014. The stool samples, which were obtained in presumptive CDI patients, were compared for their diagnostic accuracy and rapidity, including real-time polymerase chain reaction (PCR) of toxin genes, C. difficile toxin assay, and culture for C. difficile.

Results

A total of 207 cases from 116 patients were enrolled in this study and 117 cases (56.5%) were diagnosed as having CDI. Among the 117 cases, the sensitivities of real-time PCR, C. difficile toxin assay, and culture for C. difficile were 87.2% (102 cases; 95% CI, 80.7%–92.8%), 48.7% (57 cases; 95% CI, 41.0%–59.8%), and 65.0% (76 cases; 95% CI, 60.2%–78.5%), respectively (P<0.005). Notably, 34 cases (29.0%) were diagnosed with CDI by real-time PCR only. The time required to obtain results was 2.27 hours (136.62±82.51 minutes) for real-time PCR, 83.67 hours (5,020.66±3,816.38 minutes) for toxin assay, and 105.79 hours (6,347.68±3,331.46 minutes) for culture (P<0.005), respectively.

Conclusions

We confirmed that real-time PCR of toxin genes is the most effective diagnostic method for accurate and early diagnosis of CDI. It also helps to diagnose hypervirulent CDI, such as ribotype 027 infection.

Citations

Citations to this article as recorded by  
  • Clostridium Difficile Infection in Childhood: Case Series
    P. Parusheva, L. Pekova, S. Angelova, B. Bureva
    Acta Medica Bulgarica.2025; 52(s1): 98.     CrossRef
  • Usefulness of Stool Multiplex Polymerase Chain Reaction Assays in Patients with Acute Diarrhea
    Seo Hyun Kim, You Sun Kim, Seung Hyuk Kim, Won Eui Yoon, Hee Jun Myung, Jeong Seop Moon, Dong Hee Whang
    The Korean Journal of Gastroenterology.2022; 79(3): 118.     CrossRef
  • Persistent Leg Drainage in a Pediatric Trauma Patient
    Ashley Howard, Michelle R. Rychalsky, Thomas S. Murray
    Pediatric Infectious Disease Journal.2021; 40(6): 597.     CrossRef
  • Real-Time Detection and Motion Recognition of Human Moving Objects Based on Deep Learning and Multi-Scale Feature Fusion in Video
    Meimei Gong, Yiming Shu
    IEEE Access.2020; 8: 25811.     CrossRef
  • Temporal change of risk factors in hospital-acquired Clostridioides difficile infection using time-trend analysis
    Jiyoun Song, Bevin Cohen, Philip Zachariah, Jianfang Liu, Elaine L. Larson
    Infection Control & Hospital Epidemiology.2020; 41(9): 1048.     CrossRef
  • Incidence and Characteristics ofClostridioides difficileInfection in Children
    Heera Jeong, Ji-Man Kang, Jong Gyun Ahn
    Pediatric Infection & Vaccine.2020; 27(3): 158.     CrossRef
  • RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention
    Jung Hoon Song, You Sun Kim
    Gut and Liver.2019; 13(1): 16.     CrossRef
  • Is Clostridium difficile infection a real threat in patients with ulcerative colitis? A prospective, multicenter study in Korea
    Dae Bum Kim, Kang-Moon Lee, Sang Hyoung Park, You Sun Kim, Eun Soo Kim, Jun Lee, Sung-Ae Jung, Geom Seog Seo, Ji Min Lee
    Intestinal Research.2018; 16(2): 267.     CrossRef
  • 8,850 View
  • 94 Download
  • 7 Web of Science
  • 8 Crossref
Close layer
Ophthalmologic manifestations in patients with inflammatory bowel disease
Hye Jin Lee, Hyun Joo Song, Jin Ho Jeong, Heung Up Kim, Sun-Jin Boo, Soo-Young Na
Intest Res 2017;15(3):380-387.   Published online June 12, 2017
DOI: https://doi.org/10.5217/ir.2017.15.3.380
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), has been reported to have various ophthalmologic manifestations. The aim of this study was to evaluate the prevalence of ophthalmologic manifestations associated with IBD in Korea.

Methods

Sixty-one patients were examined between May 2013 and October 2014. We performed complete ophthalmologic examinations.

Results

Findings included 36 patients with CD and 25 with UC. The mean age of the patients was 34±16 years and disease duration was 45.3±23.9 months. Ophthalmologic manifestations were positive in 44 cases. Primary complication was diagnosed in 5 cases, as follows; iritis in 2 cases, episcleritis in one case, iritis with optic neuritis in 1 case, and serous retinal detachment in 1 case, without secondary complications. The most common coincidental complication was dry eye syndrome (DES), in 35 patients (57.4%). The prevalence of DES in the control group was 21.3%. The proportion of DES in patients with IBD was significantly higher than in the control group (P=0.002).

Conclusions

Ophthalmologic manifestations were high (72.1%) in IBD patients. Clinically significant primary ocular inflammation occurred in 8.2% of patients. The most common complication was DES. There was a higher rate of DES in patients with IBD compared to the control group. Evaluation of the eye should be a routine component in patients with IBD.

Citations

Citations to this article as recorded by  
  • The causal effects of inflammatory bowel disease on its ocular manifestations: A Mendelian randomization study
    Lian Luo, Xiaowei Tang, Jia Xu, Yuxi Bao, Xinyue Hu, Xiaolin Zhong, David Chau
    PLOS ONE.2025; 20(3): e0316437.     CrossRef
  • Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
    Yakup Kilic, Shahed Kamal, Farah Jaffar, Danujan Sriranganathan, Mohammed Nabil Quraishi, Jonathan P Segal
    Inflammatory Bowel Diseases.2024; 30(2): 230.     CrossRef
  • Isoliquiritin Ameliorates Ulcerative Colitis in Rats through Caspase 3/HMGB1/TLR4 Dependent Signaling Pathway
    Zhiwei Miao, Mingjia Gu, Faisal Raza, Hajra Zafar, Jianyi Huang, Yuhang Yang, Muhammad Sulaiman, Jing Yan, Yi Xu
    Current Gene Therapy.2024; 24(1): 73.     CrossRef
  • Use of Systemic Steroids for Inflammatory Bowel Disease Can Increase Intraocular Pressure
    Amrik Gil, Madeline Alizadeh, Daniel Yarmovsky, Ramya Swamy, Uni Wong
    Gastro Hep Advances.2024; 3(4): 536.     CrossRef
  • Ocular lesions in patients with ulcerative colitis
    Antonina V. Varvarynets, Valerii D. Beliayev, Mykhailo M. Hechko, Artur V. Kurakh
    Wiadomości Lekarskie.2024; 77(3): 445.     CrossRef
  • The risk for ophthalmological conditions in ulcerative colitis: A population‐based case–control study. Is silica dust‐exposure associated with inflammatory eye disease?
    Karim Makdoumi, Lucyn Ayoub, Ing‐Liss Bryngelsson, Pål Graff, Pernilla Wiebert, Per Vihlborg
    Acta Ophthalmologica.2024; 102(7): 828.     CrossRef
  • Ocular Manifestations of IBD: Pathophysiology, Epidemiology, and Iatrogenic Associations of Emerging Treatment Strategies
    Holly Richardson, Giho Yoon, George Moussa, Aditi Kumar, Philip Harvey
    Biomedicines.2024; 12(12): 2856.     CrossRef
  • Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review
    Bruno Songel-Sanchis, Jesús Cosín-Roger
    Diagnostics.2024; 14(24): 2815.     CrossRef
  • Optical coherence tomography angiography findings of retinal vascular structures in children with celiac disease
    Ishak Isik, Lutfiye Yaprak, Asli Yaprak, Ulas Akbulut
    Journal of American Association for Pediatric Ophthalmology and Strabismus.2022; 26(2): 69.e1.     CrossRef
  • Ocular Manifestations in Patients with Inflammatory Bowel Disease in the Biologics Era
    Alix Cuny, Lucas Guillo, Cédric Baumann, Patrick Netter, Silvio Danese, Bénédicte Caron, Laurent Peyrin-Biroulet, Karine Angioi
    Journal of Clinical Medicine.2022; 11(15): 4538.     CrossRef
  • The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Jing-Xing Li, Chun-Chi Chiang, San-Ni Chen, Jane-Ming Lin, Yi-Yu Tsai
    International Journal of Environmental Research and Public Health.2022; 19(23): 15683.     CrossRef
  • Ocular Manifestations of Inflammatory Bowel Disease
    Janaki Shah, Aaditya Shah, Lynn Hassman, Alexandra Gutierrez
    Inflammatory Bowel Diseases.2021; 27(11): 1832.     CrossRef
  • Ocular manifestations of inflammatory bowel diseases: an update for gastroenterologists
    Fabio CASTELLANO, Giovanni ALESSIO, Carmela PALMISANO
    Minerva Gastroenterology.2021;[Epub]     CrossRef
  • The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review
    Dominika Jakubczyk, Katarzyna Leszczyńska, Sabina Górska
    Nutrients.2020; 12(7): 1973.     CrossRef
  • Les manifestations oculaires au cours de la maladie de Crohn
    D. Saadouli, K. Ben Mansour, M. Farae, I. Loukil, S. Yahyaoui, M.A. El Afrit
    Journal Français d'Ophtalmologie.2020; 43(10): 1025.     CrossRef
  • Evaluation of Objective Signs and Subjective Symptoms of Dry Eye Disease in Patients with Inflammatory Bowel Disease
    Zsolt Barta, Levente Czompa, Aniko Rentka, Eva Zold, Judit Remenyik, Attila Biro, Rudolf Gesztelyi, Judit Zsuga, Peter Szodoray, Adam Kemeny-Beke
    BioMed Research International.2019; 2019: 1.     CrossRef
  • The optimal time to perform an ophthalmic examination of patients with inflammatory bowel disease
    Ana Luiza Biancardi, Leandro Lopes Troncoso, Haroldo Vieira de Moraes Jr, Cyrla Zaltman
    Intestinal Research.2019; 17(1): 153.     CrossRef
  • Current clinical issue of skin lesions in patients with inflammatory bowel disease
    Tomoya Iida, Tokimasa Hida, Minoru Matsuura, Hisashi Uhara, Hiroshi Nakase
    Clinical Journal of Gastroenterology.2019; 12(6): 501.     CrossRef
  • Manifestaciones extraintestinales de enfermedad inflamatoria intestinal
    Amaranta Luzoro, Pablo Sabat, Leonardo Guzmán, Francisca Frias
    Revista Médica Clínica Las Condes.2019; 30(4): 305.     CrossRef
  • Corneal Manifestations of Inflammatory Bowel Disease
    Levente Czompa, Zsolt Barta, Hassan Ziad, Gabor Nemeth, Aniko Rentka, Zsuzsa Aszalos, Eva Zold, Rudolf Gesztelyi, Judit Zsuga, Peter Szodoray, Adam Kemeny-Beke
    Seminars in Ophthalmology.2019; 34(7-8): 543.     CrossRef
  • 7,418 View
  • 106 Download
  • 23 Web of Science
  • 20 Crossref
Close layer
A wide variation of the quality of colonoscopy reporting system in the real clinical practice in southeastern area of Korea
Jung Min Lee, Yu Jin Kang, Eun Soo Kim, Yoo Jin Lee, Kyung Sik Park, Kwang Bum Cho, Seong Woo Jeon, Min Kyu Jung, Hyun Seok Lee, Eun Young Kim, Jin Tae Jung, Byung Ik Jang, Kyeong Ok Kim, Yun Jin Chung, Chang Hun Yang
Intest Res 2016;14(4):351-357.   Published online October 17, 2016
DOI: https://doi.org/10.5217/ir.2016.14.4.351
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

Establishment of a colonoscopy reporting system is a prerequisite to determining and improving quality. This study aimed to investigate colonoscopists' opinions and the actual situation of a colonoscopy reporting system in a clinical practice in southeastern area of Korea and to assess the factors predictive of an inadequate reporting system.

Methods

Physicians who performed colonoscopies in the Daegu-Gyeongbuk province of Korea and were registered with the Korean Society of Gastrointestinal Endoscopy (KSGE) were interviewed via mail about colonoscopy reporting systems using a standardized questionnaire.

Results

Of 181 endoscopists invited to participate, 125 responded to the questionnaires (response rate, 69%). Most responders were internists (105/125, 84%) and worked in primary clinics (88/125, 70.4%). Seventy-one specialists (56.8%) held board certifications for endoscopy from the KSGE. A median of 20 colonoscopies (interquartile range, 10–47) was performed per month. Although 88.8% of responders agreed that a colonoscopy reporting system is necessary, only 18.4% (23/125) had achieved the optimal reporting system level recommended by the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. One-third of endoscopists replied that they did not use a reporting document for the main reasons of "too busy" and "inconvenience." Non-endoscopy specialists and primary care centers were independent predictive factors for failure to use a colonoscopy reporting system.

Conclusions

The quality of colonoscopy reporting systems varies widely and is considerably suboptimal in actual clinical practice settings in southeastern Korea, indicating considerable room for quality improvements in this field.

Citations

Citations to this article as recorded by  
  • Association of Poor Differentiation or Positive Vertical Margin with Residual Disease in Patients with Subsequent Colectomy after Complete Macroscopic Endoscopic Resection of Early Colorectal Cancer
    Ki Ju Kim, Hyun Seok Lee, Seong Woo Jeon, Sun Jin, Sang Won Lee
    Gastroenterology Research and Practice.2017; 2017: 1.     CrossRef
  • Derivation and validation of a risk scoring model to predict advanced colorectal neoplasm in adults of all ages
    Hyo‐Joon Yang, Sungkyoung Choi, Soo‐Kyung Park, Yoon Suk Jung, Kyu Yong Choi, Taesung Park, Ji Yeon Kim, Dong Il Park
    Journal of Gastroenterology and Hepatology.2017; 32(7): 1328.     CrossRef
  • Screening strategy for colorectal cancer according to risk
    Dong Soo Han
    Journal of the Korean Medical Association.2017; 60(11): 893.     CrossRef
  • 7,295 View
  • 36 Download
  • 3 Web of Science
  • 3 Crossref
Close layer
Case Report
Familial Mediterranean Fever With Complete Symptomatic Remission During Pregnancy
Kwang Taek Kim, Hyun Joo Jang, Jae Eun Lee, Mi Kang Kim, Jun Jae Yoo, Gye Yeon Lee, Sea Hyub Kae, Jin Lee
Intest Res 2015;13(3):287-290.   Published online June 9, 2015
DOI: https://doi.org/10.5217/ir.2015.13.3.287
AbstractAbstract PDFPubReader

Familial Mediterranean fever (FMF) is an inherited autosomal recessive disorder, ethnically restricted and commonly found among populations surrounding the Mediterranean Sea. FMF is the most prevalent autoinflammatory disease; is characterized by recurrent, self-limited episodes of fever with serositis; and is caused by Mediterranean fever gene (MEFV) mutations on chromosome 16. We describe a case of adult-onset FMF with complete symptomatic remission during pregnancy, without the use of colchicine. A 25-year-old woman had presented with periodic fever, abdominal pain, and vomiting since she was 21. Her abdominal computed tomography scan showed intestinal nonrotation. She underwent exploratory laparotomy and appendectomy for her symptoms 1 year prior. She had a symptom-free pregnancy period, but abdominal pain and fever recurred after delivery. Mutation analysis of the MEFV gene revealed two point mutations (p.Leu110Pro and p.Glu148Gln). We report an adult female patient with FMF in Korea with complete symptomatic remission during pregnancy.

Citations

Citations to this article as recorded by  
  • A Case of Familial Mediterranean Fever With Severe Attacks During Withdrawal Bleeding After Controlled Ovarian Hyperstimulation
    Mio Tatara, Yuji Tanaka, Akie Takebayashi, Shunichiro Tsuji, Takashi Murakami
    Cureus.2024;[Epub]     CrossRef
  • Inherited Autoinflammatory Disease with Immunodeficiency Combined with IgA Nephropathy
    Zhifeng Jiang, Aiqiao Feng, L I Tao
    Aktuelle Rheumatologie.2020; 45(06): 574.     CrossRef
  • A Case of Schnitzler's Syndrome without Monoclonal Gammopathy-Associated Chronic Urticaria Treated with Anakinra
    Min Joo Ahn, Ji Eun Yu, Jiung Jeong, Da Woon Sim, Young-Il Koh
    Yonsei Medical Journal.2018; 59(1): 154.     CrossRef
  • Thiol/disulphide homeostasis in pregnant women with Familial Mediterranean fever
    Aykan Yucel, Cem Yasar Sanhal, Korkut Daglar, Ozgur Kara, Dilek Uygur, Ozcan Erel
    Redox Report.2016; 21(6): 287.     CrossRef
  • 8,371 View
  • 56 Download
  • 3 Web of Science
  • 4 Crossref
Close layer
Original Articles
Risk Factors for Delayed Post-Polypectomy Bleeding
Min Jung Kwon, You Sun Kim, Song I Bae, Young Il Park, Kyung Jin Lee, Jung Hwa Min, Soo Yeon Jo, Mi Young Kim, Hye Jin Jung, Seong Yeon Jeong, Won Jae Yoon, Jin Nam Kim, Jeong Seop Moon
Intest Res 2015;13(2):160-165.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.160
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

Among the many complications that can occur following therapeutic endoscopy, bleeding is the most serious, which occurs in 1.0-6.1% of all colonoscopic polypectomies. The aim of this study was to identify risk factors of delayed post-polypectomy bleeding (PPB).

Methods

We retrospectively reviewed the data of patients who underwent colonoscopic polypectomy between January 2003 and December 2012. We compared patients who experienced delayed PPB with those who did not. The control-to-patient ratio was 3:1. The clinical data analyzed included polyp size, number, location, and shape, patient' body mass index (BMI), preventive hemostasis, and endoscopist experience.

Results

Of 1,745 patients undergoing colonoscopic polypectomy, 21 (1.2%) experienced significant delayed PPB. We selected 63 age- and sex-matched controls. Multivariate logistic regression analysis showed that polyps >10 mm (odds ratio [OR], 2.605; 95% confidence interval [CI], 1.035-4.528; P=0.049), a pedunculated polyp (OR, 3.517; 95% CI, 1.428-7.176; P=0.045), a polyp located in the right hemicolon (OR, 3.10; 95% CI, 1.291-5.761; P=0.013), and a high BMI (OR, 3.681; 95% CI, 1.876-8.613; P=0.013) were significantly associated with delayed PPB.

Conclusions

Although delayed PPB is a rare event, more caution is needed during colonoscopic polypectomies performed in patients with high BMI or large polyps, pedunculated polyps, or polyps located in the right hemicolon.

Citations

Citations to this article as recorded by  
  • The Use of Clips to Prevent Post-Polypectomy Bleeding: A Clinical Review
    Matthew A. O’Mara, Peter G. Emanuel, Aaron Tabibzadeh, Robert J. Duve, Jonathan S. Galati, Gregory Laynor, Samantha Gross, Seth A. Gross
    Journal of Clinical Gastroenterology.2024; 58(8): 739.     CrossRef
  • Is endoscopic hemostasis safe and effective for delayed post-polypectomy bleeding?
    Jae-Yong Cho, Yunho Jung, Han Hee Lee, Jung-Wook Kim, Kee Myung Lee, Hyun Lim, Geun-Hyuk Choi, Seong Woo Choi, Bo-In Lee
    International Journal of Gastrointestinal Intervention.2024; 13(4): 122.     CrossRef
  • Colonic polypectomy in 2024: hot or cold?
    K Ferdinande, L Desomer, D De Looze, D.J. Tate
    Acta Gastro Enterologica Belgica.2024; 87(4): 505.     CrossRef
  • Cost-Effectiveness of Earlier or More Intensive Colorectal Cancer Screening in Overweight and Obese Patients
    Aaron Yeoh, Ajitha Mannalithara, Uri Ladabaum
    Clinical Gastroenterology and Hepatology.2023; 21(2): 507.     CrossRef
  • Prophylactic clipping to prevent delayed colonic post-polypectomy bleeding: meta-analysis of randomized and observational studies
    Kirles Bishay, Zhao Wu Meng, Levi Frehlich, Matthew T. James, Gilaad G. Kaplan, Michael J. Bourke, Robert J. Hilsden, Steven J. Heitman, Nauzer Forbes
    Surgical Endoscopy.2022; 36(2): 1251.     CrossRef
  • Establishment of a model for predicting delayed post-polypectomy bleeding: A real-world retrospective study
    Yu Lu, Xiaoying Zhou, Han Chen, Chao Ding, Xinmin Si
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Blood group O is a risk factor for delayed post-polypectomy bleeding
    Hiroto Furuhashi, Akira Dobashi, Naoto Tamai, Nana Shimamoto, Masakuni Kobayashi, Shingo Ono, Yuko Hara, Hiroaki Matsui, Shunsuke Kamba, Hideka Horiuchi, Akio Koizumi, Tomohiko R. Ohya, Masayuki Kato, Keiichi Ikeda, Hiroshi Arakawa, Kazuki Sumiyama
    Surgical Endoscopy.2021; 35(12): 6882.     CrossRef
  • Effect of Instruction on Preventing Delayed Bleeding after Colorectal Polypectomy and Endoscopic Mucosal Resection
    Takuya Okugawa, Tadayuki Oshima, Keisuke Nakai, Hirotsugu Eda, Akio Tamura, Ken Hara, Tomohiro Ogawa, Tomoaki Kono, Takashi Kondo, Katsuyuki Tozawa, Masashi Fukushima, Toshihiko Tomita, Hirokazu Fukui, Jiro Watari, Hiroto Miwa
    Journal of Clinical Medicine.2021; 10(5): 928.     CrossRef
  • Endoscopic characteristics influencing postpolypectomy bleeding in 1147 consecutive pedunculated colonic polyps: a multicenter retrospective study
    Teppei Tagawa, Masayoshi Yamada, Takeyoshi Minagawa, Masanori Sekiguchi, Kenichi Konda, Hirohito Tanaka, Hiroyuki Takamaru, Masau Sekiguchi, Taku Sakamoto, Takahisa Matsuda, Aya Kuchiba, Hitoshi Yoshida, Yutaka Saito
    Gastrointestinal Endoscopy.2021; 94(4): 803.     CrossRef
  • Delayed Bleeding After Endoscopic Resection of Colorectal Polyps: Identifying High-Risk Patients
    Oliver Bendall, Joel James, Katarzyna M Pawlak, Sauid Ishaq, J Andy Tau, Noriko Suzuki, Steven Bollipo, Keith Siau
    Clinical and Experimental Gastroenterology.2021; Volume 14: 477.     CrossRef
  • Prevention of delayed post-polypectomy bleeding: Should we amend the 2017 ESGE Guideline?
    Alexandra Mack, Dileep Mangira, Alan Moss
    Endoscopy International Open.2020; 08(09): E1111.     CrossRef
  • Prophylactic hemoclips in prevention of delayed post-polypectomy bleeding for ≥ 1 cm colorectal polyps: meta-analysis of randomized controlled trials
    Faisal Kamal, Muhammad A. Khan, Salman Khan, Hemnishil K. Marella, Tamara Nelson, Zubair Khan, Dina Ahmad, Claudio Tombazzi, Mohammad K. Ismail, Colin W. Howden
    Endoscopy International Open.2020; 08(09): E1102.     CrossRef
  • Child-Pugh B or C Cirrhosis Increases the Risk for Bleeding Following Colonoscopic Polypectomy
    Hosim Soh, Jaeyoung Chun, Seung Wook Hong, Seona Park, Yun Bin Lee, Hyun Jung Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jong Pil Im, Yoon Jun Kim, Joo Sung Kim, Jung-Hwan Yoon
    Gut and Liver.2020; 14(6): 755.     CrossRef
  • Risk factors for delayed hemorrhage after colonoscopic postpolypectomy: Polyp size and operative modality
    Changqin Liu, Ruijin Wu, Xiaomin Sun, Chunhua Tao, Zhanju Liu
    JGH Open.2019; 3(1): 61.     CrossRef
  • Risk factors for severe complications of colonoscopy in screening programs
    Mercedes Vanaclocha-Espi, Josefa Ibáñez, Ana Molina-Barceló, María José Valverde-Roig, Elena Pérez, Andreu Nolasco, Mariola de la Vega, Isabel Diez de la Lastra-Bosch, María Elena Oceja, Josep Alfons Espinàs, Rebeca Font, Francisco Pérez-Riquelme, Eunate
    Preventive Medicine.2019; 118: 304.     CrossRef
  • Adverse events related to colonoscopy: Global trends and future challenges
    Su Young Kim, Hyun-Soo Kim, Hong Jun Park
    World Journal of Gastroenterology.2019; 25(2): 190.     CrossRef
  • Clips for managing perforation and bleeding after colorectal endoscopic mucosal resection
    A. S. Turan, G. Ultee, E. J. M. Van Geenen, P. D. Siersema
    Expert Review of Medical Devices.2019; 16(6): 493.     CrossRef
  • Prospective analysis of delayed colorectal post-polypectomy bleeding
    Soo-Kyung Park, Jeong Yeon Seo, Min-Gu Lee, Hyo-Joon Yang, Yoon Suk Jung, Kyu Yong Choi, Hungdai Kim, Hyung Ook Kim, Kyung Uk Jung, Ho-Kyung Chun, Dong Il Park
    Surgical Endoscopy.2018; 32(7): 3282.     CrossRef
  • Histologic discrepancy between endoscopic forceps biopsy and endoscopic mucosal resection specimens of colorectal polyp in actual clinical practice
    Moon Joo Hwang, Kyeong Ok Kim, A Lim Kim, Si Hyung Lee, Byung Ik Jang, Tae Nyeun Kim
    Intestinal Research.2018; 16(3): 475.     CrossRef
  • Screening colonoscopy and risk of adverse events among individuals undergoing fecal immunochemical testing in a population‐based program: A nested case‐control study
    Eunate Arana-Arri, Natale Imaz-Ayo, Mari Jose Fernández, Isabel Idigoras, Isabel Bilbao, Luis Bujanda, Fidencio Bao, Enrique Ojembarrena, Ines Gil, Iñaki Gutiérrez-Ibarluzea, Isabel Portillo
    United European Gastroenterology Journal.2018; 6(5): 755.     CrossRef
  • Evaluation and management of lower gastrointestinal bleeding
    Aun Raza Shah, Vikram Jala, Hammad Arshad, Mohammad Bilal
    Disease-a-Month.2018; 64(7): 321.     CrossRef
  • Endoscopic treatment of surgery or procedure-related gastrointestinal bleeding
    Ki Bae Bang, Hyun Deok Shin
    International Journal of Gastrointestinal Intervention.2018; 7(3): 112.     CrossRef
  • Risk factors for delayed colonic post-polypectomy bleeding: a systematic review and meta-analysis
    Veeravich Jaruvongvanich, Narut Prasitlumkum, Buravej Assavapongpaiboon, Sakolwan Suchartlikitwong, Anawin Sanguankeo, Sikarin Upala
    International Journal of Colorectal Disease.2017; 32(10): 1399.     CrossRef
  • Association between the ulcer status and the risk of delayed bleeding after the endoscopic mucosal resection of colon
    Gwang‐Un Kim, Myeongsook Seo, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Jeong‐Sik Byeon
    Journal of Gastroenterology and Hepatology.2017; 32(11): 1846.     CrossRef
  • Clinical outcome of endoscopic management in delayed postpolypectomy bleeding
    Jeong-Mi Lee, Wan Soo Kim, Min Seob Kwak, Sung-Wook Hwang, Dong-Hoon Yang, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
    Intestinal Research.2017; 15(2): 221.     CrossRef
  • Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
    Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Yonsei Medical Journal.2017; 58(1): 150.     CrossRef
  • Prediction and Prevention of Postpolypectomy Bleeding: Necessity of a Different Approach for Patients Using Antithrombotic Agents
    Duk Hwan Kim
    Clinical Endoscopy.2017; 50(3): 217.     CrossRef
  • Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia
    Nam Hee Kim, Mi Yeon Lee, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Yonsei Medical Journal.2017; 58(5): 918.     CrossRef
  • A Quality Improvement Educational Intervention to Increase Knowledge of Cardiogastroenterology Amongst Medical Trainees and Nursing Staff
    Elena Fradkov, Alexander Goldowsky, Kirsten Quiles, Renee Williams
    MedEdPORTAL.2017;[Epub]     CrossRef
  • New Quality Measure Will Disincentivize Endoscopic Resection of Most Important Colorectal Lesions
    Douglas K. Rex, Thomas F. Imperiale
    Gastroenterology.2016; 150(5): 1249.     CrossRef
  • A new quality indicator of colonoscopy: caveat emptor
    Thomas F. Imperiale, Douglas K. Rex
    Gastrointestinal Endoscopy.2016; 84(3): 507.     CrossRef
  • Anesthetist-Directed Sedation for Colonoscopy: A Safe Haven or Siren’s Song?
    Douglas K. Rex, John J. Vargo
    Gastroenterology.2016; 150(4): 801.     CrossRef
  • Complication de la coloscopie
    D. Heresbach
    EMC - Gastro-entérologie.2016; 33(4): 1.     CrossRef
  • 18,731 View
  • 84 Download
  • 37 Web of Science
  • 33 Crossref
Close layer
What's the Clinical Features of Colitis in Elderly People in Long-Term Care Facilities?
So Yoon Yoon, Sung-Ae Jung, Sun-Kyung Na, Jae-In Ryu, Hye-Won Yun, Min-Jin Lee, Eun-Mi Song, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim
Intest Res 2015;13(2):128-134.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.128
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

As life expectancy has increased, the number of elderly patients who need long-term care has grown rapidly. Mortality in patients with colitis in long-term care facilities (LTCFs) is increasing. We intend to investigate the main causes of colitis in LTCFs compared to those of colitis in local communities, and to identify the clinical features and risk factors of patients with colitis in LTCFs.

Methods

We retrospectively analyzed epidemiology, medical conditions, laboratory values, diagnoses, and clinical courses of elderly patients aged ≥65 who were admitted to the Ewha Womans University hospital with colitis between January 2007 and July 2012.

Results

Patients with colitis in LTCFs (n=20) were compared with elderly patients with colitis in local communities (n=154). Fifty-five percent of colitis in LTCFs was caused by Clostridium difficile infection (CDI), 30% was due to ischemic colitis, and 15% was due to non-specific colitis. Non-specific colitis was the most common (63%) in the community group. Clinical outcomes were also significantly different between both groups: higher mortality (10.0% vs. 0.64%, P=0.021), higher requirement for intensive care units care (50.0% vs. 18.8%, P<0.01) in LTCFs group. In univariate analysis, the most significant risk factor for death in patients in LTCFs was decreased mental faculties.

Conclusions

Patients in LTCFs showed worse clinical outcomes and a much higher prevalence of CDI compared to patients from local communities. We suggest early and active evaluation, such as endoscopic examination, for differential diagnosis in patients in LTCFs.

Citations

Citations to this article as recorded by  
  • RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention
    Jung Hoon Song, You Sun Kim
    Gut and Liver.2019; 13(1): 16.     CrossRef
  • A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn’s Disease in the Elderly Population
    David Kim, Sasha Taleban
    Drugs & Aging.2019; 36(7): 607.     CrossRef
  • Rapid and accurate diagnosis of Clostridium difficile infection by real-time polymerase chain reaction
    Pil Hun Song, Jung Hwa Min, You Sun Kim, Soo Yeon Jo, Eun Jin Kim, Kyung Jin Lee, Jeonghun Lee, Hyun Sung, Jeong Seop Moon, Dong Hee Whang
    Intestinal Research.2018; 16(1): 109.     CrossRef
  • Acute hemorrhagic rectal ulcer syndrome: Comparison with non‐hemorrhagic rectal ulcer lower gastrointestinal bleeding
    Joo Hyuk Jung, Jong Wook Kim, Hyun Woo Lee, Min Yong Park, Woo Hyun Paik, Won Ki Bae, Nam‐Hoon Kim, Kyung‐Ah Kim, June Sung Lee
    Journal of Digestive Diseases.2017; 18(9): 521.     CrossRef
  • Coexisting cytomegalovirus infection in immunocompetent patients with Clostridium difficile colitis
    Khee-Siang Chan, Wen-Ying Lee, Wen-Liang Yu
    Journal of Microbiology, Immunology and Infection.2016; 49(6): 829.     CrossRef
  • Clinical Outcomes in Hospitalized Patients withClostridium difficileInfection by Age Group
    Ho Chan Lee, Kyeong Ok Kim, Yo Han Jeong, Si Hyung Lee, Byung Ik Jang, Tae Nyeun Kim
    The Korean Journal of Gastroenterology.2016; 67(2): 81.     CrossRef
  • 4,953 View
  • 36 Download
  • 6 Web of Science
  • 6 Crossref
Close layer
Old Age at Diagnosis Is Associated With Favorable Outcomes in Korean Patients With Inflammatory Bowel Disease
Jae Hyuk Choi, Eun Soo Kim, Kwang Bum Cho, Kyung Sik Park, Yoo Jin Lee, Sang Min Lee, Yu Jin Kang, Byung Ik Jang, Kyeong Ok Kim
Intest Res 2015;13(1):60-67.   Published online January 29, 2015
DOI: https://doi.org/10.5217/ir.2015.13.1.60
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

Despite the rising incidence and prevalence of inflammatory bowel disease (IBD) in Asian populations, data regarding clinical characteristics of patients in Asia based on age at diagnosis are relatively sparse. The aim of this study was to compare clinical characteristics based on the age at diagnosis according to the Montreal Classification in Korean IBD patients.

Methods

We recruited consecutive patients with IBD at two tertiary hospitals and retrospectively reviewed their medical information. Patients were divided into three groups according to their age at diagnosis: youth (<17 years), young adult (17-40 years), and middle-old (>40 years). The main clinical characteristics for comparison were the achievement of a remission state at the last follow-up visit, cumulative rate of surgery, and cumulative use of immunomodulators and tumor necrosis factor-α (TNFα) blockers during the follow-up period.

Results

In total, 346 IBD patients were included (Crohn's disease [CD] 146 and ulcerative colitis 200; 36 youth, 202 young adult, and 113 middle-old). The middle-old group with CD was characterized by a predominance of uncomplicated behavior (P=0.013) and a lower frequency of perianal disease (P=0.009). The middle-old group was associated more with a less aggressive disease course than the younger group, as shown by more frequent remission (P=0.004), being less likely to undergo surgery (P<0.001), and lower cumulative use of immunomodulators and TNFα blockers (P<0.001).

Conclusions

Age at diagnosis according to the Montreal Classification is an important prognostic factor for Korean IBD patients.

Citations

Citations to this article as recorded by  
  • Impact of age at diagnosis on long‐term prognosis in patients with intestinal Behçet's disease
    Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
    Journal of Gastroenterology and Hepatology.2024; 39(3): 519.     CrossRef
  • Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: A meta-analysis
    Wei Fu, Hu Fu, Weixia Ye, Yinsuo Han, Xianqiang Liu, Sirui Zhu, Hongmin Li, Rong Tang, Qin Wang
    International Immunopharmacology.2021; 101: 108235.     CrossRef
  • Earlier Anti-Tumor Necrosis Factor Therapy of Crohn’s Disease Correlates with Slower Progression of Bowel Damage
    Hinaben Panchal, Mathilde Wagner, Manjil Chatterji, Bachir Taouli, Russell McBride, Jeromy R. Patterson, Ryan Ungaro, Marla Dubinsky, Judy Cho, David B. Sachar
    Digestive Diseases and Sciences.2019; 64(11): 3274.     CrossRef
  • Characteristics and management of patients with inflammatory bowel disease between a secondary and tertiary hospitals: a propensity score analysis
    Ki Hwan Song, Eun Soo Kim, Yoo Jin Lee, Byung Ik Jang, Kyeong Ok Kim, Sang Gyu Kwak, Hyun Seok Lee
    Intestinal Research.2018; 16(2): 216.     CrossRef
  • Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease
    Yoo Min Han, Hyuk Yoon, Soo Lim, Mi-Kyung Sung, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Joo Sung Kim
    Gut and Liver.2017; 11(3): 363.     CrossRef
  • Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research
    Shaocun Zhang, Xiaocang Cao, He Huang
    Frontiers in Cellular and Infection Microbiology.2017;[Epub]     CrossRef
  • Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study
    Sung Wook Hwang, Jee Hyun Kim, Jong Pil Im, Byong Duk Ye, Hoon Sup Koo, Kyu Chan Huh, Jae Hee Cheon, You Sun Kim, Young Ho Kim, Dong Soo Han, Won Ho Kim, Joo Sung Kim
    Journal of Gastroenterology and Hepatology.2017; 32(10): 1716.     CrossRef
  • Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases
    Young Sun Kim, Sung-Ae Jung, Kang-Moon Lee, Soo Jung Park, Tae Oh Kim, Chang Hwan Choi, Hyun Gun Kim, Won Moon, Chang Mo Moon, Hye Kyoung Song, Soo-Young Na, Suk-Kyun Yang
    Intestinal Research.2017; 15(3): 338.     CrossRef
  • Clinical Efficacy of Beclomethasone Dipropionate in Korean Patients with Ulcerative Colitis
    Yoon Jee Lee, Jae Hee Cheon, Jae Hyun Kim, SunHo Yoo, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim
    Yonsei Medical Journal.2017; 58(1): 144.     CrossRef
  • Prediction of low bone mineral density in patients with inflammatory bowel diseases
    Solvey Schüle, Jean‐Benoît Rossel, Diana Frey, Luc Biedermann, Michael Scharl, Jonas Zeitz, Natália Freitas‐Queiroz, Valérie Pittet, Stephan R Vavricka, Gerhard Rogler, Benjamin Misselwitz
    United European Gastroenterology Journal.2016; 4(5): 669.     CrossRef
  • Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission
    Jae Hyun Kim, Jae Hee Cheon, Yehyun Park, Hyun Jung Lee, Soo Jung Park, Tae Il Kim, Won Ho Kim
    Scandinavian Journal of Gastroenterology.2016; 51(9): 1069.     CrossRef
  • Patients with perianal Crohn's disease have poor disease outcomes after primary bowel resection
    Yoo Min Han, Ji Won Kim, Seong‐Joon Koh, Byeong Gwan Kim, Kook Lae Lee, Jong Pil Im, Joo Sung Kim, Hyun Chae Jung
    Journal of Gastroenterology and Hepatology.2016; 31(8): 1436.     CrossRef
  • Clinical features of Crohn's disease in Korean patients residing in Busan and Gyeongnam
    Eun Ji Lee, Tae Oh Kim, Geun Am Song, Jong hun Lee, Hyung Wook Kim, Sam Ryong Jee, Seun Ja Park, Hyun Jin Kim, Jong Ha Park
    Intestinal Research.2016; 14(1): 30.     CrossRef
  • The Positive Influences of Increasing Age at Diagnosis of Inflammatory Bowel Disease on Disease Prognostication in Asian Perspective
    Raja Affendi Raja Ali
    Intestinal Research.2015; 13(1): 4.     CrossRef
  • Continuous duodenal levodopa infusion in a patient with Crohn's disease and small bowel surgery — Case report
    Svetlana Tomic, Danijela Skelac, Dario Mick, Ivan Segec, Bojan Resan, Silva Butkovic Soldo
    Journal of the Neurological Sciences.2015; 358(1-2): 525.     CrossRef
  • 6,326 View
  • 54 Download
  • 15 Web of Science
  • 15 Crossref
Close layer
Is the Environment of the Endoscopy Unit a Reservoir of Pathogens?
Eun Sung Choi, Jae Hyuk Choi, Jung Min Lee, Sang Min Lee, Yoo Jin Lee, Yu Jin Kang, Eun Soo Kim, Kwang Bum Cho, Kyung Sik Park, Byoung Kuk Jang, Jae Seok Hwang, Woo Jin Chung, Nam Hee Ryoo, Seong Woo Jeon, Min Kyu Jung
Intest Res 2014;12(4):306-312.   Published online October 27, 2014
DOI: https://doi.org/10.5217/ir.2014.12.4.306
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Given the characteristic procedures involved in the endoscopy unit, the spread of pathogens is much more frequent in this unit than in other environments. However, there is a lack of data elucidating the existence of pathogens in the endoscopy unit. The aim of this study was to detect the presence of possible pathogens in the endoscopy unit.

Methods

We performed environmental culture using samples from the endoscopy rooms of 2 tertiary hospitals. We used sterile cotton-tipped swabs moistened with sterile saline to swab the surfaces of 197 samples. Then, we cultured the swab in blood agar plate. Samples from the colonoscopy room were placed in thioglycollate broth to detect the presence of anaerobes. After 2 weeks of culture period, we counted the colony numbers.

Results

The most commonly contaminated spots were the doctor's keyboard, nurse's cart, and nurse's mouse. The common organisms found were non-pathogenic bacterial microorganisms Staphylococcus, Micrococcus, and Streptococcus spp.. No definite anaerobe organism was detected in the colonoscopy room.

Conclusions

Although the organisms detected in the endoscopy unit were mainly non-pathogenic organisms, they might cause opportunistic infections in immunocompromised patients. Therefore, the environment of the endoscopy room should be managed appropriately; moreover, individual hand hygiene is important for preventing possible hospital-acquired infections.

Citations

Citations to this article as recorded by  
  • Speech Recognition System Generates Highly Accurate Endoscopic Reports in Clinical Practice
    Hiroshi Takayama, Toshitatsu Takao, Ryo Masumura, Yoshikazu Yamaguchi, Ryo Yonezawa, Hiroya Sakaguchi, Yoshinori Morita, Takashi Toyonaga, Kazutaka Izumiyama, Yuzo Kodama
    Internal Medicine.2023; 62(2): 153.     CrossRef
  • What’s on your keyboard? A systematic review of the contamination of peripheral computer devices in healthcare settings
    Nicole Ide, Bianca K Frogner, Cynthia M LeRouge, Patrick Vigil, Matthew Thompson
    BMJ Open.2019; 9(3): e026437.     CrossRef
  • Addressing Bacterial Surface Contamination in Radiology Work Spaces
    Alexander Harvin, Kyle VanMiddlesworth, Jonathan Botstein, Robert Hazelrigg, Jeanne Hill, Paul Thacker
    Journal of the American College of Radiology.2016; 13(10): 1271.     CrossRef
  • 8,091 View
  • 49 Download
  • 3 Web of Science
  • 3 Crossref
Close layer
Long-Term Clinical Outcome of Clostridium difficile Infection in Hospitalized Patients: A Single Center Study
Young Seok Doh, You Sun Kim, Hye Jin Jung, Young Il Park, Jin Won Mo, Hyun Sung, Kyung Jin Lee, Young Ki Seo, Jeong Seop Moon, Seong Woo Hong
Intest Res 2014;12(4):299-305.   Published online October 27, 2014
DOI: https://doi.org/10.5217/ir.2014.12.4.299
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Antibiotic usage and increasingly aging populations have led to increased incidence of Clostridium difficile infection (CDI) in worldwide. Recent studies in Korea have also reported increasing CDI incidence; however, there have been no reports on the long-term outcomes of CDI. We therefore investigated the long-term clinical outcomes of patients with CDI, including delayed recurrence, associated risk factors and mortality.

Methods

Hospitalized patients diagnosed with CDI at Seoul Paik Hospital between January 2007 and December 2008 were included. Their medical records were retrospectively investigated. 'Delayed recurrence' was defined as a relapse 8 weeks after a successful initial treatment. Multivariate logistic regression analysis was performed to identify risk factors for the delayed recurrence. Kaplan-Meier curves were used to analyze mortality rates.

Results

A total of 120 patients were enrolled; among them, 87 were followed-up for at least 1 year, with a mean follow-up period of 34.1±25.1 months. Delayed recurrence was observed in 17 patients (19.5%), and significant risk factors were age (over 70 years, P=0.049), nasogastric tube insertion (P=0.008), and proton pump inhibitor or H2-blocker treatments (P=0.028). The 12- and 24-month mortality rates were 24.6% and 32.5%, respectively. No deaths were directly attributed to CDI.

Conclusions

Delayed recurrence of CDI was not rare, occurring in 19.5% of the study population. Although CDI-related mortality was not reported, 2-year (32.5%) mortality rate of CDI patients implies that a CDI diagnosis may predict severe morbidity and poor prognosis of the underlying disease.

Citations

Citations to this article as recorded by  
  • Global, regional, and national burdens of Clostridioides difficile infection over recent decades: a trend analysis informed by the Global Burden of Disease Study
    Jianmei Zhou, Jie Zhu, Pengyue Zhang, Chunhui Tao, Xiaodan Hong, Zhenhua Zhang, Yuan Pin Hung, Bobby G. Warren
    Microbiology Spectrum.2025;[Epub]     CrossRef
  • Fecal microbiota composition is a better predictor of recurrent Clostridioides difficile infection than clinical factors in a prospective, multicentre cohort study
    Tessel M. van Rossen, Yvette H. van Beurden, Johannes A. Bogaards, Andries E. Budding, Chris J.J. Mulder, Christina M.J.E. Vandenbroucke-Grauls
    BMC Infectious Diseases.2024;[Epub]     CrossRef
  • Clinical characteristics and outcomes of Clostridioides difficile infection in the intensive care unit: a KASID multi-centre study
    J.E. Baek, I.H. Choi, Y.W. Cho, J. Kim, Y.J. Lee, M.C. Kim, K.O. Kim, Y-S. Cho
    Journal of Hospital Infection.2023; 139: 106.     CrossRef
  • Predictive Factors for Death among Patients with Clostridium difficile Infection – A Single Center Experience Study
    Vlad A. Ionescu, Camelia C. Diaconu, Raluca S. Costache, Florentina Gheorghe, Andreea G. Andronesi, Gina Gheorghe
    Romanian Journal of Military Medicine.2023; 126(4): 492.     CrossRef
  • Review of the Impact of Biofilm Formation on Recurrent Clostridioides difficile Infection
    Daira Rubio-Mendoza, Adrián Martínez-Meléndez, Héctor Jesús Maldonado-Garza, Carlos Córdova-Fletes, Elvira Garza-González
    Microorganisms.2023; 11(10): 2525.     CrossRef
  • The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model
    Qiaomai Xu, Shumeng Zhang, Jiazheng Quan, Zhengjie Wu, Silan Gu, Yunbo Chen, Beiwen Zheng, Longxian Lv, Lanjuan Li
    Applied Microbiology and Biotechnology.2022; 106(19-20): 6689.     CrossRef
  • Fecal Microbiota Transplantation May Be the Best Option in Treating Multiple Clostridioides difficile Infection: A Network Meta-Analysis
    Fanni Dembrovszky, Noémi Gede, Zsolt Szakács, Péter Hegyi, Szabolcs Kiss, Nelli Farkas, Zsolt Molnár, Marcell Imrei, Dóra Dohos, Zoltán Péterfi
    Infectious Diseases and Therapy.2021; 10(1): 201.     CrossRef
  • A newly isolated E. thailandicus strain d5B with exclusively antimicrobial activity against C. difficile might be a novel therapy for controlling CDI
    Tinghua Li, Lin Lyu, Yan Zhang, Ke Dong, Qingtian Li, Xiaokui Guo, Yongzhang Zhu
    Genomics.2021; 113(1): 475.     CrossRef
  • Evaluation of Connecticut medical providers’ concordance with 2017 IDSA/SHEA Clostridioides difficile treatment guidelines in New Haven County, 2018–2019
    Casey Morgan Luc, Danyel Olson, David B. Banach, Paula Clogher, James Hadler
    Infection Control & Hospital Epidemiology.2021; 42(5): 549.     CrossRef
  • External validation of two prediction tools for patients at risk for recurrent Clostridioides difficile infection
    Tessel M. van Rossen, Laura J. van Dijk, Martijn W. Heymans, Olaf M. Dekkers, Christina M. J. E. Vandenbroucke-Grauls, Yvette H. van Beurden
    Therapeutic Advances in Gastroenterology.2021;[Epub]     CrossRef
  • RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients’ Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections
    Sahil Khanna, Darrell S Pardi, Courtney Jones, William D Shannon, Carlos Gonzalez, Ken Blount
    Clinical Infectious Diseases.2021; 73(7): e1613.     CrossRef
  • Epidemiology of community-acquired and recurrent Clostridioides difficile infection
    Yichun Fu, Yuying Luo, Ari M Grinspan
    Therapeutic Advances in Gastroenterology.2021;[Epub]     CrossRef
  • Long term outcomes of Hospital-Identified Clostridium Difficile Infection (HICDI): A retrospective cohort analysis of adult patients in a teaching hospital
    Pandhem Samarasimha R, Michael David, Singh Manoj Y
    Global Journal of Medical and Clinical Case Reports.2021; : 008.     CrossRef
  • Recommendations and guidelines for the treatment of Clostridioides difficile infection in Taiwan
    Kuan-Sheng Wu, Ling-Shan Syue, Aristine Cheng, Ting-Yu Yen, Hsien-Meng Chen, Yu-Hsin Chiu, Yu-Lung Hsu, Chun-Hsiang Chiu, Ting-Yi Su, Wan-Lin Tsai, Wei-Yu Chen, Chung-Hao Huang, Huei-Min Hung, Ling-Ju Huang, Hong-Jie Kuo, Pei-Chin Lin, Ching-Hsiang Yang,
    Journal of Microbiology, Immunology and Infection.2020; 53(2): 191.     CrossRef
  • Fecal Microbiota Transplantation in Recurrent Clostridium Difficile Infection: Is it Superior to Other Conventional Methods?
    Zayar Lin, Zafar Iqbal, Juan Fernando Ortiz, Sawleha Arshi Khan, Nusrat Jahan
    Cureus.2020;[Epub]     CrossRef
  • RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention
    Jung Hoon Song, You Sun Kim
    Gut and Liver.2019; 13(1): 16.     CrossRef
  • Nasogastric tube and outcomes of Clostridium difficile infection: A systematic review and meta‐analysis
    Karn Wijarnpreecha, Suthanya Sornprom, Charat Thongprayoon, Parkpoom Phatharacharukul, Wisit Cheungpasitporn
    Journal of Evidence-Based Medicine.2018; 11(1): 40.     CrossRef
  • Rapid and accurate diagnosis of Clostridium difficile infection by real-time polymerase chain reaction
    Pil Hun Song, Jung Hwa Min, You Sun Kim, Soo Yeon Jo, Eun Jin Kim, Kyung Jin Lee, Jeonghun Lee, Hyun Sung, Jeong Seop Moon, Dong Hee Whang
    Intestinal Research.2018; 16(1): 109.     CrossRef
  • Retrospective analysis of long-term gastrointestinal symptoms after Clostridium difficile infection in a nonelderly cohort
    Tamar F. Barlam, Rene Soria-Saucedo, Omid Ameli, Howard J. Cabral, Warren A. Kaplan, Lewis E. Kazis, Abhishek Deshpande
    PLOS ONE.2018; 13(12): e0209152.     CrossRef
  • The risk of Clostridium difficile associated diarrhea in nasogastric tube insertion: A systematic review and meta-analysis
    Karn Wijarnpreecha, Suthanya Sornprom, Charat Thongprayoon, Parkpoom Phatharacharukul, Wisit Cheungpasitporn, Kiran Nakkala
    Digestive and Liver Disease.2016; 48(5): 468.     CrossRef
  • Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication
    Yu Mi Lee, Kyu Chan Huh, Soon Man Yoon, Byung Ik Jang, Jeong Eun Shin, Hoon Sup Koo, Yunho Jung, Sae Hee Kim, Hee Seok Moon, Seung Woo Lee
    Gut and Liver.2016; 10(2): 250.     CrossRef
  • Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
    Jung Hwa Min, You Sun Kim
    Gut and Liver.2016; 10(4): 493.     CrossRef
  • An Unusual Case of Proctitis and Rectal Abscess due to Irritants byArtemisia asiaticaSmoke (Ssukjwahun)
    Seunghyup Kim, You Sun Kim, Seo Hyun Kim, Dong Hoon Lee, Se Jun Park, Seo Young Yun, Dae Young Kim, Jeonghun Lee, Jeong Seop Moon
    The Korean Journal of Gastroenterology.2016; 67(4): 212.     CrossRef
  • Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients
    Youngouk Ro, Chang Soo Eun, Hyun Soo Kim, Ji Yeoun Kim, Young Jae Byun, Kyo-Sang Yoo, Dong Soo Han
    Gut and Liver.2016; 10(4): 581.     CrossRef
  • Risk Factors for Delayed Recurrence ofClostridium difficileInfection
    Ji Won Kim
    Intestinal Research.2014; 12(4): 266.     CrossRef
  • 6,997 View
  • 60 Download
  • 22 Web of Science
  • 25 Crossref
Close layer
Is Colonoscopy Necessary after Computed Tomography Diagnosis of Acute Diverticulitis?
Min Jung Kim, Young Sik Woo, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Poong-Lyul Rhee, Jae J. Kim, Soon Jin Lee, Young-Ho Kim
Intest Res 2014;12(3):221-228.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.221
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

A diagnosis of acute diverticulitis is based on computed tomography (CT). Colonoscopy is commonly performed after the acute event to exclude other diagnoses. This study aimed to determine whether colonoscopy is necessary and what additional information is gained from a colonoscopy after acute diverticulitis.

Methods

Acute diverticulitis was diagnosed by clinical criteria and characteristic CT findings. We analyzed the number of patients in whom colorectal cancers were diagnosed and other incidental findings of polyps and other diseases.

Results

A total of 177 patients were analyzed retrospectively. The mean age was 43.3±15.3 years (range, 13-82 years) and 97 patients (54.8%) were male. Sixty-one patients had undergone a colonoscopy within 1 year of the acute attack. Advanced adenomatous lesions and colonic malignancy were not detected. Nineteen patients (31.1%) had ≥1 polyp and 11 patients (18.0%) had an adenomatous polyp. No new or different diagnosis was made after colonoscopy. None of the 116 patients who did not undergo colonoscopy within a year after acute diverticulitis had a diagnosis of colorectal cancer registered with the Korea Central Cancer Registry.

Conclusions

Routine colonoscopy yields little benefit in patients with acute diverticulitis diagnosed by typical clinical symptoms and CT. The current practice of a colonoscopy after acute diverticulitis needs to be reevaluated.

Citations

Citations to this article as recorded by  
  • Endoscopic findings after CT proven acute diverticulitis: a systematic review and meta‐analysis
    Amy Millicent Yesheng Cao, Vincent Wai Lam, Matthew John Francis Xavier Rickard
    ANZ Journal of Surgery.2023; 93(5): 1150.     CrossRef
  • Infection or Inflammation: Are Uncomplicated Acute Appendicitis, Acute Cholecystitis, and Acute Diverticulitis Infectious Diseases?
    Philip S. Barie, Lillian S. Kao, Mikayla Moody, Robert G. Sawyer
    Surgical Infections.2023; 24(2): 99.     CrossRef
  • Risk for colorectal cancer after computed tomography verified acute diverticulitis: A retrospective cohort study with long-term follow-up
    Leena-Mari Mäntymäki, Juha Grönroos, Markus Riskumäki, Tero Vahlberg, Jukka Karvonen
    Scandinavian Journal of Surgery.2023; 112(3): 157.     CrossRef
  • Diagnosis and management of acute colonic diverticulitis: results of a survey among Korean gastroenterologists
    Jae Gon Lee, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Shin Hee Lee, Myung-Won You, Seong-Eun Kim
    The Korean Journal of Internal Medicine.2023; 38(5): 672.     CrossRef
  • Comparative outcomes of acute colonic diverticulitis in immunocompromised versus immunocompetent patients: a systematic review and meta-analysis
    Jae Gon Lee, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Shin Hee Lee, Myung-Won You, Seong-Eun Kim
    Intestinal Research.2023; 21(4): 481.     CrossRef
  • Diagnosis and Treatment of Colonic Diverticular Disease
    You Sun Kim
    The Korean Journal of Gastroenterology.2022; 79(6): 233.     CrossRef
  • Diverticulitis does not increase the long-term risk of developing colon cancer: a systematic review and meta-analysis
    Laura Quitzau Mortensen, Jens Buciek, Kristoffer Andresen, Jacob Rosenberg
    International Journal of Colorectal Disease.2022; 37(9): 1945.     CrossRef
  • Acute complicated diverticulitis is associated with an increased advanced neoplasia diagnosis rate
    Fadi Abu Baker, Mohanad Ganayem, Amir Mari, Randa Taher, Mohamad Suki, Yael Kopelman
    Medicine.2021; 100(5): e24271.     CrossRef
  • Systematic Review and Meta-analysis on Colorectal Cancer Findings on Colonic Evaluation After CT-Confirmed Acute Diverticulitis
    Chee Hoe Koo, Jasmine H.E. Chang, Nicholas L. Syn, Ian J.Y. Wee, Ronnie Mathew
    Diseases of the Colon & Rectum.2020; 63(5): 701.     CrossRef
  • Risk of Colorectal Cancer in Patients With Acute Diverticulitis: A Systematic Review and Meta-analysis of Observational Studies
    Jeremy Meyer, Lorenzo A. Orci, Christophe Combescure, Alexandre Balaphas, Philippe Morel, Nicolas C. Buchs, Frédéric Ris
    Clinical Gastroenterology and Hepatology.2019; 17(8): 1448.     CrossRef
  • What radiologists should know about tomographic evaluation of acute diverticulitis of the colon
    Aline de Araújo Naves, Giuseppe D'Ippolito, Luis Ronan Marquez Ferreira Souza, Sílvia Portela Borges, Glênio Moraes Fernandes
    Radiologia Brasileira.2017; 50(2): 126.     CrossRef
  • High Probability of an Underlying Colorectal Cancer Among Patients Treated for Acute Diverticulitis. A Population‐Based Cohort Follow‐Up Study
    Carl Johan Grahnat, Sebastian Hérard, Annicka Ackzell, Roland E. Andersson
    World Journal of Surgery.2016; 40(9): 2283.     CrossRef
  • Colonoscopy after Hinchey I and II left-sided diverticulitis: utility or futility?
    Avery S. Walker, Jason R. Bingham, Karmon M. Janssen, Eric K. Johnson, Justin A. Maykel, Omar Ocampo, John P. Gonzalez, Scott R. Steele
    The American Journal of Surgery.2016; 212(5): 837.     CrossRef
  • 15,830 View
  • 91 Download
  • 15 Web of Science
  • 13 Crossref
Close layer
A Clinical Analysis of Gastrointestinal Stromal Tumors in Small Intestine: Comparison of Bleeding and Non-bleeding Group
Sang Jin Lee, Jong Kyu Park, Hyun Il Seo, Koon Hee Han, Young Don Kim, Woo Jin Jeong, Gab Jin Cheon, Jae Seok Song
Intest Res 2013;11(2):113-119.   Published online April 30, 2013
DOI: https://doi.org/10.5217/ir.2013.11.2.113
AbstractAbstract PDF
Background/Aims
Gastrointestinal stromal tumors (GIST) in the small intestine are rare and can cause bleeding. The study investigated the clinical characteristics of GIST in the small intestine and to determine the factors related to gastrointestinal bleeding. Methods: We retrospectively evaluated the clinical outcomes of 22 patients with small bowel GIST who were pathologically diagnosed at Gangneung Asan Hospital between March 1997 and August 2012. Results: The median age was 63.5 (38-82) years. Nine patients (40.9%) had gastrointestinal bleeding, five patients (22.7%) had abdominal pain, two patients (9%) had palpable mass. The site of tumor was the duodenum in nine cases (40.9%), jejunum in 7 cases (31.8%), and ileum in six cases (27.3%). Most patients underwent small bowel resection or wedge resection but three patients underwent pancreaticoduodenectomy. Tumor size ranged from 1.6 to 19 cm (median 6.5 cm). The median mitotic rate was 2 (0-50)/50 high power fields (HPF). The median mitotic rate was 2 (0-50)/50 HPF. Five patients (25%) showed recurrence. Gender, aspirin or warfarin use, size and mitotic index of tumor, hospital stay, recurrence and survival were not significantly different between bleeding and non-bleeding group. Bleeding group showed older age, proximal location in small intestine and mucosal ulceration significantly. Conclusions: Small bowel GISTs with bleeding were marked by older age, mucosal ulceration and location of proximal small bowel (duodenum and jejunum) rather than distal small bowel (ileum). (Intest Res 2013;11:113-119)

Citations

Citations to this article as recorded by  
  • Prognostic Significance of Ki-67 Expression in Patients Undergoing Surgical Resection for Gastrointestinal Stromal Tumor
    Seong Yeon Jeong, Won Wo Park, You Sun Kim, Young Il Park, Seung Hyup Kim, Won Jae Yoon, Jeong Seop Moon, Byung Mo Lee, Seong Woo Hong, Yun Kyung Kang
    The Korean Journal of Gastroenterology.2014; 64(2): 87.     CrossRef
  • 2,655 View
  • 16 Download
  • 1 Crossref
Close layer
Clinical Predictors Associated with the Severity of Colonic Diverticulitis
Su Jin Lee, Jeong Eun Shin, Sun Young Cho, Hoon Choi, Do Hyun Lee, Woo Hee Cho, Ha Yan Kang, Bae Hwan Kim, Joon Hyuk Lee, Hyun Duk Shin, Il Han Song
Intest Res 2013;11(1):23-27.   Published online January 31, 2013
DOI: https://doi.org/10.5217/ir.2013.11.1.23
AbstractAbstract PDF
Background/Aims
Colonic diverticular diseases are increasing in Korea due to aging of the population and westernization of people's lifestyle. The aim of this study was to investigate the clinical predictors associated with the severity of colonic diverticulitis in Korea. Methods: We retrospectively reviewed the medical records of 107 patients who were hospitalized with diverticulitis and underwent abdominopelvic computerized tomography at Dankook University Hospital between March 2002 and August 2011. The severity of colonic diverticulitis was evaluated by using Modified Hinchey classification, stage 0 to stage Ia were classified as mild group and stage Ib to stage IV were classified as severe group. Patients' records were assessed for age, sex, underlying diseases, history of diverticulitis, associated symptoms, location of diverticulitis, white blood cells, and C-reactive protein (CRP). Results: Male to female ratio was 1.6:1 with the mean age of 43.1 years. Eighty-three patients (77.6%) were in the mild group and 24 patients (22.4%) were in the severe group. In multivariated analysis, the clinical predictors associated with the severity of colonic diverticulitis were left location (odds ratio [OR], 7.268; P=0.030), duration of symptoms (≥3 days; OR, 4.174; P=0.022), and elevated CRP (≥5 mg/dL; OR, 4.576; P=0.018). Conclusions: Left location, duration of symptom, and elevated CRP were the meaningful predictors for severity of colonic diverticulitis. When confronting with patients with these risk factors, we should keep in mind about the possibility of severe diverticulitis. (Intest Res 2013;11:23-27)

Citations

Citations to this article as recorded by  
  • Is Colonoscopy Necessary after Computed Tomography Diagnosis of Acute Diverticulitis?
    Min Jung Kim, Young Sik Woo, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Poong-Lyul Rhee, Jae J. Kim, Soon Jin Lee, Young-Ho Kim
    Intestinal Research.2014; 12(3): 221.     CrossRef
  • 2,725 View
  • 39 Download
  • 1 Crossref
Close layer
Case Report
Rare Case of Ogilvie Syndrome Associated with Herpes Zoster
Ji Hyun Kim, Suck-Ho Lee, Gyeong Jae Na, Su Jin Lee, Yeong Geol Jo, Tae Hoon Lee, Il Kwun Chung, Sang Heum Park, Sun Joo Kim
Intest Res 2012;10(4):379-382.   Published online October 31, 2012
DOI: https://doi.org/10.5217/ir.2012.10.4.379
AbstractAbstract PDF
Acute colonic pseudo-obstruction (Ogilvie syndrome) associated with herpes zoster is extremely rare, and few cases have been reported. An 81-year-old woman diagnosed with herpes zoster was referred for accompanying colonic ileus. The diameter of the cecum was 7 cm and a computed tomographic scan showed no definite obstructive cause. Because the patient showed minimal improvement with conservative treatment, endoscopic colonic decompression was performed successfully. Previous studies revealed that the treatment of Ogilvie syndrome associated with herpes zoster does not differ from that of other conditions, and the role of the varicella-zoster virus in this syndrome is unclear. Here, we present the first case of Ogilvie syndrome associated with herpes zoster in Korea, which was improved by endoscopic colonic decompression. (Intest Res 2012;10:379-382)

Citations

Citations to this article as recorded by  
  • Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific
    Liang-Kung Chen, Hidenori Arai, Liang-Yu Chen, Ming-Yueh Chou, Samsuridjal Djauzi, Birong Dong, Taro Kojima, Ki Tae Kwon, Hoe Nam Leong, Edward M. F. Leung, Chih-Kuang Liang, Xiaohong Liu, Dilip Mathai, Jiun Yit Pan, Li-Ning Peng, Eduardo Rommel S. Poblet
    BMC Infectious Diseases.2017;[Epub]     CrossRef
  • Acute Colonic Pseudo-Obstruction (Ogilvie’s syndrome) as a Complication of Herpes Zoster
    Kyung-Sun Min
    The Korean Journal of Medicine.2016; 90(4): 318.     CrossRef
  • 2,813 View
  • 15 Download
  • 2 Crossref
Close layer
Original Article
The Usefulness of Double Balloon Enteroscopy for Diagnosis and Treatment of Small Bowel Diseases
Min Ho Choi, Kyung Hae Lee, Je Hyun Ryu, Seung Yong Han, Hyeon Woo Byun, Dong Hee Koh, Hyun Joo Jang, Chang Soo Eun, Sea Hyub Kae, Jin Lee
Intest Res 2008;6(1):31-36.   Published online June 30, 2008
AbstractAbstract PDF
Background/Aims
Double balloon eneterscopy is a promising endoscopic method to examine the entire small bowel and to conduct therapeutic procedures. This study was performed to evaluate the clinical outcome and usefulness of double balloon enteroscopy. Methods: We enrolled patients with suspected small bowel disease. Double balloon enteroscopy was performed in 61 patients and 89 procedures were undetaken between August 2004 and October 2007 at Hangang Sacred Heart Hospital. Results: Indications for double balloon enteroscopy were obscure gastrointestinal bleeding, chronic abdominal pain or diarrhea and the presence of a suspicious small bowel tumor. Double balloon enteroscopy contributed to the diagnosis of small bowel diseases in 82.0% of patients. In 46 patients (75.4%), specific treatments were influenced by the results of double balloon enteroscopy. There were no significant complications. Conclusions: Double balloon enteroscopy is one of the most useful methods for the diagnosis and treatment of small bowel disease. (Intest Res 2008;6:31-36)
  • 1,911 View
  • 15 Download
Close layer
Review
Current State of Small Bowel Investigation: Practical Use of Double Balloon Enteroscopy
Hyun Joo Jang, Jin Lee
Intest Res 2007;5(1):13-18.   Published online June 30, 2007
AbstractAbstract PDF
The small intestine has been regarded as the most difficult area of the gastrointestinal tract to investigate by endoscopic view. Capsule endoscopy provided a complete evaluation of the small bowel and has become one of the major approaches in diagnosis of suspected small bowel diseases. However, this technique has several limitations, including its inability to perform conventional endoscopic procedures, taking biopsy specimens, and therapeutic interventions. Another novel method, double balloon enteroscopy, introduced by Yamamoto et al. in 2001, makes it possible to overcome these limitations. Since then, several studies have reported diagnostic and therapeutic outcomes. In this brief review, the authors summarized the current clinical outcomes and practical use of double balloon enteroscopy in suspected small bowel disorders. (Intest Res 2007;5:13-18)
  • 1,468 View
  • 16 Download
Close layer

Intest Res : Intestinal Research
Close layer
TOP